Researchers from Teva Pharmaceuticals and Immuneering have developed and published in PLOS One a computational approach for comparing and assessing the biological impacts of branded and generic drugs.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
In Science this week: role for RNA splicing in genetic variation, and more.
An advocacy group sues the US Food and Drug Administration over redactions of information about advisory committee members, Stat News reports.
Mexico is trying to lure young genomics researchers back home with their own labs, Science reports.
A molecular autopsy has aided a woman's search for why sudden cardiac death has stalked her family, the Wall Street Journal reports.